Robin Mathieson

Robin Mathieson currently serves as a Doctor of Physical Therapy and Specialty Pharmaceuticals Sales Manager at Novo Nordisk, where she leverages her clinical expertise and strategic sales acumen to advance the company's mission in delivering innovative healthcare solutions. In her role, Robin has been instrumental in developing and executing targeted sales strategies that foster strong partnerships with healthcare providers, including endocrinologists, diabetologists, and specialty care clinics. Her deep understanding of medical terminology and patient care pathways enables her to effectively communicate complex product information, ensuring that healthcare professionals are well-informed about Novo Nordisk’s portfolio of specialty pharmaceuticals.

Robin’s key projects often involve launching new therapies for chronic conditions such as diabetes and obesity, where she collaborates closely with cross-functional teams to align sales initiatives with regulatory compliance and market needs. Her leadership in implementing innovative tactics—such as digital engagement platforms and tailored educational programs—has significantly contributed to exceeding sales targets and increasing brand visibility in competitive markets. Her skills in project management and transaction management enable her to oversee multiple initiatives simultaneously, ensuring seamless execution from planning to delivery.

With a strong foundation in analytical skills and a keen eye for market trends, Robin continuously identifies opportunities for growth and process improvements. Her expertise in training and front/back office operations further enhances her ability to lead her team effectively, fostering a culture of compliance, professionalism, and customer-centricity. Overall, Robin Mathieson’s blend of clinical knowledge, strategic sales management, and industry-specific skills positions her as a vital contributor to Novo Nordisk’s ongoing success in the specialty pharmaceuticals landscape.